Display options
Share it on

World J Clin Cases. 2014 May 16;2(5):126-32. doi: 10.12998/wjcc.v2.i5.126.

Animal models of atherosclerosis.

World journal of clinical cases

Fatemeh Ramezani Kapourchali, Gangadaran Surendiran, Li Chen, Elisabeth Uitz, Babak Bahadori, Mohammed H Moghadasian

Affiliations

  1. Fatemeh Ramezani Kapourchali, Mohammed H Moghadasian, International Nutrition Research Inc., Winnipeg, MB R3T2G4, Canada.

PMID: 24868511 PMCID: PMC4023305 DOI: 10.12998/wjcc.v2.i5.126

Abstract

In this mini-review several commonly used animal models of atherosclerosis have been discussed. Among them, emphasis has been made on mice, rabbits, pigs and non-human primates. Although these animal models have played a significant role in our understanding of induction of atherosclerotic lesions, we still lack a reliable animal model for regression of the disease. Researchers have reported several genetically modified and transgenic animal models that replicate human atherosclerosis, however each of current animal models have some limitations. Among these animal models, the apolipoprotein (apo) E-knockout (KO) mice have been used extensively because they develop spontaneous atherosclerosis. Furthermore, atherosclerotic lesions developed in this model depending on experimental design may resemble humans' stable and unstable atherosclerotic lesions. This mouse model of hypercholesterolemia and atherosclerosis has been also used to investigate the impact of oxidative stress and inflammation on atherogenesis. Low density lipoprotein (LDL)-r-KO mice are a model of human familial hypercholesterolemia. However, unlike apo E-KO mice, the LDL-r-KO mice do not develop spontaneous atherosclerosis. Both apo E-KO and LDL-r-KO mice have been employed to generate other relevant mouse models of cardiovascular disease through breeding strategies. In addition to mice, rabbits have been used extensively particularly to understand the mechanisms of cholesterol-induced atherosclerosis. The present review paper details the characteristics of animal models that are used in atherosclerosis research.

Keywords: Animal models; Atherosclerosis; Disease; Dyslipidemia

References

  1. J Biol Chem. 1999 Dec 24;274(52):36912-20 - PubMed
  2. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12764-9 - PubMed
  3. Circulation. 2013 Jun 25;127(25):2523-34 - PubMed
  4. Circ Res. 2013 Jul 19;113(3):252-65 - PubMed
  5. Jikken Dobutsu. 1975 Jul;24(3):89-94 - PubMed
  6. J Lipid Res. 1991 Aug;32(8):1333-9 - PubMed
  7. Life Sci. 1999;64(12):1029-36 - PubMed
  8. Lab Invest. 2001 Sep;81(9):1173-83 - PubMed
  9. Atherosclerosis. 1987 Nov;68(1-2):159-73 - PubMed
  10. Arterioscler Thromb Vasc Biol. 1995 Nov;15(11):1889-99 - PubMed
  11. Psychoneuroendocrinology. 2013 May;38(5):685-93 - PubMed
  12. Atherosclerosis. 1980 Jun;36(2):261-8 - PubMed
  13. Atherosclerosis. 1991 Mar;87(1):39-46 - PubMed
  14. J Clin Invest. 1995 Aug;96(2):1118-24 - PubMed
  15. Genetics. 1992 Dec;132(4):1095-104 - PubMed
  16. Nutr Metab (Lond). 2010 Dec 10;7:89 - PubMed
  17. Histol Histopathol. 1998 Jul;13(3):797-817 - PubMed
  18. J Immunol. 2004 Mar 1;172(5):2731-8 - PubMed
  19. Exp Mol Pathol. 1979 Feb;30(1):55-73 - PubMed
  20. J Lab Clin Med. 1949 Oct;34(10):1427-42 - PubMed
  21. Circulation. 1999 Apr 6;99(13):1733-9 - PubMed
  22. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4544-9 - PubMed
  23. Nutr Metab (Lond). 2006 Mar 27;3:17 - PubMed
  24. Lancet. 1988 Oct 29;2(8618):983-6 - PubMed
  25. J Nutr. 1997 Jul;127(7):1344-8 - PubMed
  26. FEBS Lett. 1980 Aug 25;118(1):81-4 - PubMed
  27. Exp Mol Pathol. 1969 Feb;10(1):39-62 - PubMed
  28. Jikken Dobutsu. 1977 Jan;26(1):35-42 - PubMed
  29. J Biol Chem. 1995 Feb 17;270(7):2974-80 - PubMed
  30. Science. 1986 Dec 19;234(4783):1573-7 - PubMed
  31. Arzneimittelforschung. 1998 Apr;48(4):396-402 - PubMed
  32. Exp Mol Pathol. 1982 Dec;37(3):427-32 - PubMed
  33. Circ Res. 1974 Nov;35(5):722-33 - PubMed
  34. Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):415-22 - PubMed
  35. Comp Biochem Physiol A Comp Physiol. 1987;88(3):503-6 - PubMed
  36. Am J Pathol. 2010 Feb;176(2):1028-37 - PubMed
  37. Atherosclerosis. 2013 Oct;230(2):284-92 - PubMed
  38. Can J Physiol Pharmacol. 2013 Nov;91(11):960-5 - PubMed
  39. Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):119-26 - PubMed
  40. Arch Pathol. 1971 Jul;92(1):37-45 - PubMed
  41. Arteriosclerosis. 1986 Mar-Apr;6(2):155-65 - PubMed
  42. Free Radic Res. 2011 Sep;45(9):1013-23 - PubMed
  43. Circulation. 1999 Jan 19;99(2):276-83 - PubMed
  44. Am J Pathol. 1991 Jul;139(1):139-47 - PubMed
  45. J Clin Invest. 1995 May;95(5):2246-57 - PubMed
  46. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11448-53 - PubMed
  47. J Nutr Biochem. 2008 Aug;19(8):545-54 - PubMed
  48. Exp Mol Pathol. 1973 Dec;19(3):304-19 - PubMed
  49. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):926-33 - PubMed
  50. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):e174-8 - PubMed
  51. J Lipid Res. 1999 Mar;40(3):365-75 - PubMed
  52. Atherosclerosis. 2013 Dec;231(2):442-7 - PubMed
  53. Food Chem. 2012 Oct 15;134(4):2097-104 - PubMed
  54. J Biol Chem. 1997 May 23;272(21):13570-5 - PubMed
  55. Science. 1992 Oct 16;258(5081):468-71 - PubMed
  56. Exp Mol Pathol. 1975 Apr;22(2):151-75 - PubMed
  57. Circulation. 2007 Apr 24;115(16):2178-87 - PubMed
  58. J Clin Invest. 1998 Oct 15;102(8):1559-68 - PubMed
  59. Circulation. 1996 Aug 15;94(4):713-7 - PubMed
  60. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):160-7 - PubMed
  61. J Lipid Res. 1993 Aug;34(8):1367-83 - PubMed

Publication Types